{{Rsnum
|rsid=211037
|Gene=GABRG2
|Chromosome=5
|position=162101274
|Orientation=plus
|GMAF=0.3976
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=GABRG2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 57.7 | 37.8 | 4.5
| HCB | 21.5 | 44.4 | 34.1
| JPT | 20.2 | 42.2 | 37.6
| YRI | 17.5 | 55.9 | 26.6
| ASW | 24.6 | 52.6 | 22.8
| CHB | 21.5 | 44.4 | 34.1
| CHD | 13.3 | 50.5 | 36.2
| GIH | 70.0 | 28.0 | 2.0
| LWK | 18.3 | 46.8 | 34.9
| MEX | 60.7 | 33.9 | 5.4
| MKK | 34.2 | 50.3 | 15.5
| TSI | 53.5 | 42.6 | 4.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20356767
|Title=Association of alpha subunit of GABA(A) receptor subtype gene polymorphisms with epilepsy susceptibility and drug resistance in north Indian population
}}

{{PMID Auto
|PMID=22572707
|Title=Investigation of the role of the GABRG2 gene variant in migraine
}}

{{PMID Auto
|PMID=19842164
|Title=Association study between GABA receptor genes and anxiety spectrum disorders.
|OA=1
}}

{{PMID Auto
|PMID=23140995
|Title=GABRG2 rs211037 polymorphism and epilepsy: A systematic review and meta-analysis
}}

{{PMID Auto
|PMID=23287319
|Title=Lack of association between rs211037 of the GABRG2 gene and juvenile myoclonic epilepsy in Brazilian population
}}

{{PMID Auto
|PMID=24482035
|Title=Benzodiazepine-Associated Hepatic Encephalopathy Significantly Increased Healthcare Utilization and Medical Costs of Chinese Cirrhotic Patients: 7-Year Experience
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}